Repligen Corp.
- BID
122.9
- ASK
123.3
- 81 Units81 Units
- 07/22, 17:56:06 PM
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
28.16%
Market Cap
-
P/E Ratio
189.57
Dividend Yield
0.00 %
Earnings per Share
0.77 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 123.35 G | 0 Units |
| PRICE DETERMINATION TIME | 07/22/2026 / 05:46:28 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 123.35 | 120.9 |
| PREV. DAY'S PRICE | 124.85 | (07/21) |
| CHANGE DAY BEFORE | -1.50 | -1.20 % |
| 52 WEEK HIGH / LOW | 150.4 (11/26) | 86.32 (05/14) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 0.58 | -0.42 | 0.77 | 1.75 | 2.29 |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | 284.76 | - | 189.57 | 68.50 | 52.49 |
PRICE - BOOK RATIO | 5.10 | 4.09 | 4.38 | - | - |
PRICE - SALES RATIO | 16.03 | 12.69 | 12.55 | - | - |
PRICE - CASH FLOW RATIO | 88.98 | 45.91 | 78.93 | - | - |
Master Data
| WKN | 870980 |
| ISIN | US7599161095 |
| SYMBOL | RGN |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | REPLIGEN CORP. DL-,01 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -2.73 % | 9.57 % | 11.42 % | -13.66 % | 28.16 % | -10.95 % | -26.56 % | -10.24 % |
| HIGH | 130.80 | 130.80 | 130.80 | 145.65 | 150.40 | 192.40 | 279.70 | 148.15 |
| LOW | 124.85 | 109.25 | 86.32 | 86.32 | 86.32 | 86.32 | 86.32 | 86.32 |
Dividende
pro Aktie
REPLIGEN CORP. DL-,01 does not deliver dividend information
Company profile
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.
Structured products for Repligen Corp.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.